83 related articles for article (PubMed ID: 8450033)
1. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.
Agostoni A; Aygören-Pürsün E; Binkley KE; Blanch A; Bork K; Bouillet L; Bucher C; Castaldo AJ; Cicardi M; Davis AE; De Carolis C; Drouet C; Duponchel C; Farkas H; Fáy K; Fekete B; Fischer B; Fontana L; Füst G; Giacomelli R; Gröner A; Hack CE; Harmat G; Jakenfelds J; Juers M; Kalmár L; Kaposi PN; Karádi I; Kitzinger A; Kollár T; Kreuz W; Lakatos P; Longhurst HJ; Lopez-Trascasa M; Martinez-Saguer I; Monnier N; Nagy I; Németh E; Nielsen EW; Nuijens JH; O'grady C; Pappalardo E; Penna V; Perricone C; Perricone R; Rauch U; Roche O; Rusicke E; Späth PJ; Szendei G; Takács E; Tordai A; Truedsson L; Varga L; Visy B; Williams K; Zanichelli A; Zingale L
J Allergy Clin Immunol; 2004 Sep; 114(3 Suppl):S51-131. PubMed ID: 15356535
[TBL] [Abstract][Full Text] [Related]
2. alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1.
Sulikowski T; Bauer BA; Patston PA
Protein Sci; 2002 Sep; 11(9):2230-6. PubMed ID: 12192078
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of C1 inhibitor.
Davis AE
Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
[TBL] [Abstract][Full Text] [Related]
4. [Activation of plasma cascade systems in sepsis: role of C1 inhibitors].
Zeerleder S; Caliezi C; Redondo M; Devay J; Wuillemin WA
Schweiz Med Wochenschr; 1999 Oct; 129(39):1410-7. PubMed ID: 10542999
[TBL] [Abstract][Full Text] [Related]
5. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
[TBL] [Abstract][Full Text] [Related]
6. The balance between inhibition and substrate-type reactions of recombinant C1 inhibitor P5/P3 variants.
Eldering E; Huijbregts CC; Nuijens JH; Hack CE
Behring Inst Mitt; 1993 Dec; (93):125-30. PubMed ID: 8172559
[No Abstract] [Full Text] [Related]
7. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
Plotnick MI; Schechter NM; Wang ZM; Liu X; Rubin H
Biochemistry; 1997 Nov; 36(47):14601-8. PubMed ID: 9398179
[TBL] [Abstract][Full Text] [Related]
8. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
[TBL] [Abstract][Full Text] [Related]
9. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
[TBL] [Abstract][Full Text] [Related]
10. C1 inhibitor: analysis of the role of amino acid residues within the reactive center loop in target protease recognition.
Zahedi R; MacFarlane RC; Wisnieski JJ; Davis AE
J Immunol; 2001 Aug; 167(3):1500-6. PubMed ID: 11466370
[TBL] [Abstract][Full Text] [Related]
11. A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.
DONALDSON VH; EVANS RR
Am J Med; 1963 Jul; 35():37-44. PubMed ID: 14046003
[No Abstract] [Full Text] [Related]
12. Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.
Brower MS; Harpel PC
J Biol Chem; 1982 Aug; 257(16):9849-54. PubMed ID: 6980881
[TBL] [Abstract][Full Text] [Related]
13. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
Schapira M; Scott CF; Colman RW
Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.
de Agostini A; Lijnen HR; Pixley RA; Colman RW; Schapira M
J Clin Invest; 1984 Jun; 73(6):1542-9. PubMed ID: 6725552
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of the inhibition of human leucocyte elastase by eglin from the leech Hirudo medicinalis.
Baici A; Seemüller U
Biochem J; 1984 Mar; 218(3):829-33. PubMed ID: 6562888
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
